Cargando…

Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists

Type 2 diabetes mellitus is a metabolic disorder with complicated pathogenesis, and mono-target therapy often fails to effectively manage the levels of blood glucose. In recent years, the anti-diabetes target glucokinase (GK) has attracted the attention of researchers. It acts as a glucose sensor, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yixin, Li, Li, Wan, Li, Huang, Yan, Cao, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788356/
https://www.ncbi.nlm.nih.gov/pubmed/35067153
http://dx.doi.org/10.1080/14756366.2021.2025362

Ejemplares similares